share_log

Mersana Therapeutics Shares Are Trading Lower. The Company Announced Initial Clinical Data From the Phase 1 Dose Escalation and Backfill Cohorts for Emiltatug Ledadotin.

Mersana Therapeutics Shares Are Trading Lower. The Company Announced Initial Clinical Data From the Phase 1 Dose Escalation and Backfill Cohorts for Emiltatug Ledadotin.

Mersana Therapeutics的股票正在交易下跌。公司宣佈了Emiltatug Ledadotin的1期劑量遞增和補充隊列的初步臨牀數據。
Benzinga ·  06:03

Mersana Therapeutics Shares Are Trading Lower. The Company Announced Initial Clinical Data From the Phase 1 Dose Escalation and Backfill Cohorts for Emiltatug Ledadotin.

Mersana Therapeutics的股價走低。該公司公佈了來自Emiltatug Ledadotin第一階段劑量遞增和回填隊列的初步臨牀數據。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論